
    
      A Multicenter, Double-Blind, Placebo-controlled comparison of the efficacy and safety of
      flexible dose extended-release bupropion (HCl) 300-450 mg/day and placebo administered for
      eight weeks for the treatment of adult outpatients with major depressive disorder including
      symptoms of decreased energy, pleasure, and interest
    
  